Evidence map›Paper›PMID 27185325›Full record

ReviewTrends in endocrinology and metabolism: TEM2016

GPIHBP1 and Plasma Triglyceride Metabolism.

Loren G Fong, Stephen G Young, Anne P Beigneux, André Bensadoun, Monika Oberer, Haibo Jiang, Michael Ploug

Open access · greenAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. From Transcriptional Reprogramming to Fat Quality Improvement: DietaryAnimals : an open access journal from MDPI · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2024
    Review
  10. Article
  11. Article
  12. A homozygous variant in theFrontiers in genetics · 2022
    Article
  13. Article
  14. Review
  15. ANGPLT3 in cardio-metabolic disorders.Molecular biology reports · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Chylomicronemia from GPIHBP1 autoantibodies.Journal of lipid research · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Loren G FongDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Electronic address: lfong@mednet.ucla.edu.
Stephen G YoungDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Electronic address: sgyoung@mednet.ucla.edu.
Anne P BeigneuxDepartment of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
André BensadounDivision of Nutritional Science, Cornell University, Ithaca, NY 14853, USA.
Monika ObererInstitute of Molecular Biosciences, University of Graz and BioTechMed, Graz, Austria.
Haibo JiangCentre for Microscopy, Characterisation, and Analysis, The University of Western Australia.
Michael PlougFinsen Laboratory, Rigshospitalet, 2200 Copenhagen N, Denmark; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, 220 Copenhagen N, Denmark. Electronic address: m-ploug@finsenlab.dk.
University of California, Los Angeles · USBioTechMed-Graz · ATCornell University · USRigshospitalet · DKUniversity of Western Australia · AU

Funding

The Lipin Protein Family and Triglyceride Metabolism P01HL090553 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2008 to 2018
$23.3M
Refining Physiologic Mechanisms for Intravascular Triglyceride MetabolismR01HL087228 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEIGNEUX, ANNE, FONG, LOREN GI · 2007 to 2024
$7.8M
Defining mechanisms for lipid transport across capillary endothelial cellsR01HL125335 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2015 to 2017
$1.2M
NHLBI NIH HHS P01 HL090553NHLBI NIH HHS R01 HL087228NHLBI NIH HHS R01 HL125335
6 · The paper itself

Abstract

GPIHBP1, a GPI-anchored protein in capillary endothelial cells, is crucial for the lipolytic processing of triglyceride-rich lipoproteins (TRLs). GPIHBP1 shuttles lipoprotein lipase (LPL) to its site of action in the capillary lumen and is essential for the margination of TRLs along capillaries - such that lipolytic processing can proceed. GPIHBP1 also reduces the unfolding of the LPL catalytic domain, thereby stabilizing LPL catalytic activity. Many different GPIHBP1 mutations have been identified in patients with severe hypertriglyceridemia (chylomicronemia), the majority of which interfere with folding of the protein and abolish its capacity to bind and transport LPL. The discovery of GPIHBP1 has substantially revised our understanding of intravascular triglyceride metabolism but has also raised many new questions for future research.

Indexed as

AnimalsHumansHypertriglyceridemiaLipoprotein LipaseReceptors, LipoproteinTriglyceridesGPIHBP1 protein, humanLipoprotein LipaseReceptors, LipoproteinTriglycerideschylomicronemiaendothelial cellshypertriglyceridemialipid transportlipoprotein lipaseLU (Ly6/uPAR) protein family

Identifiers

PMID27185325
PMCPMC4927088
OpenAlexW2366056993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.